Cargando…
BikDDA, a Mutant of Bik with Longer Half-Life Expression Protein, Can Be a Novel Therapeutic Gene for Triple-Negative Breast Cancer
Our previous studies showed that BikDD, a constitutively active mutant form of Bik, exhibited powerful antitumor effects in preclinical pancreatic, lung and breast cancer models. Howerver, the antitumor activity of BikDD in triple-negative breast cancer (TNBC) is unknown. Here we show that aberrant...
Autores principales: | Jiao, Shiping, Wu, Minqing, Ye, Feng, Tang, Hailin, Xie, Xinhua, Xie, Xiaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956915/ https://www.ncbi.nlm.nih.gov/pubmed/24637719 http://dx.doi.org/10.1371/journal.pone.0092172 |
Ejemplares similares
-
Arabidopsis Mutant bik1 Exhibits Strong Resistance to Plasmodiophora brassicae
por: Chen, Tao, et al.
Publicado: (2016) -
Polyploids require Bik1 for kinetochore–microtubule attachment
por: Lin, Haijiang, et al.
Publicado: (2001) -
Ligand-induced BIK1 monoubiquitination regulates plant immunity
por: Ma, Xiyu, et al.
Publicado: (2020) -
Neither loss of Bik alone, nor combined loss of Bik and Noxa, accelerate murine lymphoma development or render lymphoma cells resistant to DNA damaging drugs
por: Happo, L, et al.
Publicado: (2012) -
Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis
por: Gillissen, Bernhard, et al.
Publicado: (2007)